- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06041282
Conservative Treatment of Early Adhesive Capsulitis
A Multicentre Randomized Controlled Trial of Manipulation Under Anesthesia and Supervised Home Rehabilitation in the Treatment of Early Adhesive Capsulitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: weiliang shen, doctor
- Phone Number: +86 0571 87783759
- Email: wlshen@zju.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310058
- Recruiting
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University
-
Contact:
- weiliang shen, Doctor
- Phone Number: 86-0571-86995513
- Email: wlshen@zju.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients in our hospital who need manual release of periarthritis of shoulder or home rehabilitation treatment;
- Unilateral and primary periarthritis of shoulder
- Age ≥40 years old and ≤80 years old, regardless of gender.
- Forward flexion movement is more than 50% limited compared with the contralateral.
- Duration of disease ≤3 months
Exclusion Criteria:
- Patients with a previous history of shoulder joint surgery
- Patients who did not complete the follow-up within the specified time
- Patients with other shoulder diseases.
- Patient with systemic immune disease.
- Patients who have participated in clinical trials or are conducting other clinical trials within 3 months before screening
- Patients with serious primary cardiovascular diseases, lung diseases, endocrine and metabolic diseases, or serious diseases affecting their survival, such as tumor or AIDS, are considered not suitable for admission.
- Patients with serious liver diseases, kidney diseases, hematological diseases, such as kidney function (BUN, Cr) more than the upper limit of normal, liver function (ALT, AST, TBIL) more than 2 times the upper limit of normal.
- Patients with viral hepatitis, infectious diseases, abnormal blood coagulation mechanism and other diseases that researchers consider inappropriate for surgery.
- Pregnant or lactating women, or those planning to get pregnant during the test, with positive urine HCG test results before the test; Menstruating women should wait until their period is over before undergoing surgery.
- Patients with severe neurological and mental diseases.
- Suspected or true history of alcohol and drug abuse.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: manipulation under anesthesia group
The patient underwent manipulation under anesthesia
|
After the anesthesia took effect, the patient was placed in the supine position, and the experienced surgeon stood at the head of the bed to release the affected limb by four angles of forward flexion, abduction, external rotation and internal rotation.
After the operation is completed, 1ml de Bosson (MSD) +2.5ml sodium hyaluronate (Biochemical Industries Co., LTD.) is injected once.
|
Active Comparator: Supervised home rehabilitation group
The patient underwent supervised home rehabilitation
|
The doctor instructs the patient in exercise training at the outpatient clinic.
At each clinic visit, the doctor will guide the different stages of the movement.
At the first visit, the doctor guides the patient through the first phase of the rehabilitation program to improve the patient's basic mobility.
At the first month of follow-up, the second phase of rehabilitation program was guided, and the recovery of mobility was accompanied by muscle training, including wall climbing and muscle resistance exercises.
1ml Debossone (MSD) +2.5ml sodium hyaluronate (Biochemical Industries Co., LTD.) was injected once at the clinic.
All the training required patients to do their best at home to complete 3 sets of 5 each.
At the end of each day, the patient will upload a video to the platform, and the doctor will evaluate whether the patient's recovery is in place.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Constant-Murley Score (CMS)
Time Frame: 6months after intervention
|
The Constant-Mulery score mainly includes 8 aspects related to your shoulder in the past 4 weeks. The proportion of subjective and objective components in the Constant-Mulery score is 35 points/65 points. A total of 100 points.The subjective part of the score includes the score of pain degree and the score of impact on daily life. 35 points in total.The objective part of the score includes the score of shoulder range of motion and strength. 65 points in total. |
6months after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Constant-Murley Score (CMS)
Time Frame: 1 months, 3months, and 1year after intervention
|
The Constant-Mulery score mainly includes 8 aspects related to your shoulder in the past 4 weeks. The proportion of subjective and objective components in the Constant-Mulery score is 35 points/65 points. A total of 100 points.The subjective part of the score includes the score of pain degree and the score of impact on daily life. 35 points in total.The objective part of the score includes the score of shoulder range of motion and strength. 65 points in total. |
1 months, 3months, and 1year after intervention
|
Oxford Shoulder Score (OSS)
Time Frame: 1 months, 3months, 6 months and 1year after intervention
|
The Oxford Shoulder Score (OSS) consists of 12 questions with five options each.
The light to heavy lines were assigned 1, 2, 3, 4 and 5 points respectively.
So the total score is between 12 and 60.
A score of 12 represents perfectly normal shoulder function and a score of 60 represents the most severe difficulty in shoulder function.
|
1 months, 3months, 6 months and 1year after intervention
|
Fear-avoidance belief questionnaire(FABQ)
Time Frame: 1 months, 3months, 6 months and 1year after intervention
|
The FABQ is a self-assessment scale with 16 options.
Each option has 0~6 points and 7 grades (from extremely disagreeable to extremely agreed).
"0" means completely disagreed, "6" means completely agreed, and "1~5" means not sure.
The higher the score, the more inclined to fully agree
|
1 months, 3months, 6 months and 1year after intervention
|
Insomnia Severity Index(ISI)
Time Frame: 1 months, 3months, 6 months and 1year after intervention
|
The scale is a simple tool for screening insomnia, including 7 items, which are used to evaluate the nature and symptoms of sleep disorders of subjects.
|
1 months, 3months, 6 months and 1year after intervention
|
Hospital Anxiety and Depression Scale(HADS)
Time Frame: 1 months, 3months, 6 months and 1year after intervention
|
HADS is a self-assessment scale, including two subscales, HADS-A and HADS-D, with a total of 14 items, including 7 items for anxiety (A) and 7 items for depression (D).
Each item is scored at four levels according to the frequency of symptoms in the past month.
Each item is scored at 0-3 points in four levels.
The higher the score, the more serious the anxiety or depression
|
1 months, 3months, 6 months and 1year after intervention
|
SF-36
Time Frame: 1 months, 3months, 6 months and 1year after intervention
|
SF-36 is a concise health questionnaire developed by the Boston Institute of Health, which is widely used in the measurement of the quality of life of the general population, the evaluation of clinical trials and the evaluation of health policies.
SF-36 is used to assess physiological function, physiological function, physical pain, general health, energy, social function, emotional function and mental health, which are classified into "physical health" and "mental health"
|
1 months, 3months, 6 months and 1year after intervention
|
Visual analogue scale(VAS)
Time Frame: 1 months, 3months, 6 months and 1year after intervention
|
Draw a 10cm horizontal line on the paper.
One end of the line is "0", indicating no pain; the other end is "10", indicating severe pain; The middle represents different degrees of pain; Let the patient draw a mark on the horizontal line according to their feelings to indicate the degree of pain.
|
1 months, 3months, 6 months and 1year after intervention
|
range of motion
Time Frame: 1 months, 3months, 6 months and 1year after intervention
|
Measure the patient's flexion, abduction, internal rotation and external rotation angle
|
1 months, 3months, 6 months and 1year after intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-0750
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adhesive Capsulitis
-
University of MalayaNot yet recruitingAdhesive Capsulitis of Shoulder
-
Taipei Veterans General Hospital, TaiwanRecruitingAdhesive Capsulitis of ShoulderTaiwan
-
Taif UniversityRecruitingAdhesive Capsulitis of ShoulderSaudi Arabia
-
Cairo UniversityNot yet recruitingAdhesive Capsulitis of Shoulder
-
Health Education Research Foundation (HERF)RecruitingAdhesive Capsulitis of ShoulderPakistan
-
Riphah International UniversityCompletedAdhesive Capsulitis of ShoulderPakistan
-
Balikesir UniversityCompletedAdhesive Capsulitis of Shoulder
-
Daniel G. RendeiroCompletedAdhesive Capsulitis of Shoulder | Frozen Shoulder | Shoulder Adhesive CapsulitisUnited States
-
Cairo UniversityRecruitingAdhesive Capsulitis of ShoulderEgypt
-
Riphah International UniversityCompletedAdhesive Capsulitis of ShoulderPakistan
Clinical Trials on manipulation under anesthesia
-
Akin CilTerminatedAdhesive Capsulitis of the ShoulderUnited States
-
Erasmus Medical CenterUniversitaire Ziekenhuizen KU Leuven; University of California, San Francisco; Medical Center HaaglandenRecruitingGlioblastomaUnited States, Belgium, Germany, Netherlands, Switzerland
-
Erasmus Medical CenterMassachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaboratorsRecruitingGlioblastoma | Brain Neoplasms | Recurrent Glioblastoma | Recurrent Adult Brain Tumor | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme of Brain | Brain Neoplasms, Adult, Malignant | Astrocytoma, Malignant | Brain Neoplasms, AdultUnited States, Germany, Switzerland, Belgium, Netherlands
-
Hospital de ViladecansFundacio per la recerca e investigació del Hospital de ViladecansCompleted
-
Huashan HospitalCompletedBrain Neoplasms | Surgery | HyperemiaChina
-
Grant SandersCompletedSubluxation of Joint of Lumbar Spine
-
University of Nevada, Las VegasCompleted
-
Wenzhou Medical UniversityUnknownCorneal Opacity | Corneal Dystrophies, Hereditary | Keratitis, Herpetic | Corneal UlcerChina
-
Canadian Memorial Chiropractic CollegeMcMaster UniversityTerminatedAnkle Inversion SprainCanada
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedPregnancy Related | Regional Anesthesia Morbidity | Postdural Puncture HeadacheTurkey